• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病在动脉粥样硬化患者中的高患病率。

High prevalence of COPD in atherosclerosis patients.

作者信息

Tuleta Izabela, Farrag Tarik, Busse Laura, Pizarro Carmen, Schaefer Christian, Pingel Simon, Nickenig Georg, Skowasch Dirk, Schahab Nadjib

机构信息

Department of Internal Medicine II - Cardiology, Pulmonology and Angiology, University of Bonn, Bonn, Germany.

出版信息

Int J Chron Obstruct Pulmon Dis. 2017 Oct 19;12:3047-3053. doi: 10.2147/COPD.S141988. eCollection 2017.

DOI:10.2147/COPD.S141988
PMID:29089753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5655122/
Abstract

Atherosclerosis and COPD are both systemic inflammatory diseases that may influence each other. The aim of the present study was to determine the prevalence of COPD in patients with cerebral and/or peripheral artery disease and to assess factors associated with the presence of COPD. Following the diagnosis of cerebral and/or peripheral artery disease by means of duplex sonography, 166 consecutive patients underwent body plethysmography with capillary blood gas analysis. Thereafter, blood tests with determination of different parameters such as lipid profile, inflammatory and coagulation markers were conducted in remaining 136 patients who fulfilled inclusion criteria of the study. Thirty-six out of 136 patients suffered from COPD, mostly in early stages of the disease. Residual volume indicating emphysema was increased (162.9%±55.9% vs 124.5%±37.0%, <0.05) and diffusion capacity was decreased (55.1%±19.5% vs 75.3%±18.6%, <0.05) in COPD patients vs non-COPD group. In capillary blood gas analysis, COPD patients had lower partial pressure of oxygen (70.9±11.5 vs 75.2±11.0 mmHg, <0.05) and higher partial pressure of carbon dioxide (36.8±7.5 vs 34.4±4.4 mmHg, <0.05) compared with non-COPD individuals. Presence of COPD was associated with predominance of diabetes mellitus, interleukin-8-related systemic neutrophilic inflammation and anemia. In conclusion, COPD is highly prevalent in patients with atherosclerotic artery disease.

摘要

动脉粥样硬化和慢性阻塞性肺疾病(COPD)都是可能相互影响的全身性炎症性疾病。本研究的目的是确定患有脑和/或外周动脉疾病患者中COPD的患病率,并评估与COPD存在相关的因素。通过双功超声诊断脑和/或外周动脉疾病后,166例连续患者接受了体容积描记法和毛细血管血气分析。此后,对符合研究纳入标准的其余136例患者进行了血液检测,以测定不同参数,如血脂谱、炎症和凝血标志物。136例患者中有36例患有COPD,大多处于疾病早期。与非COPD组相比,COPD患者中提示肺气肿的残气量增加(162.9%±55.9%对124.5%±37.0%,<0.05),而弥散能力降低(55.1%±19.5%对75.3%±18.6%,<0.05)。在毛细血管血气分析中,与非COPD个体相比,COPD患者的氧分压较低(70.9±11.5对75.2±11.0 mmHg,<0.05),二氧化碳分压较高(36.8±7.5对34.4±4.4 mmHg,<0.05)。COPD的存在与糖尿病占主导、白细胞介素-8相关的全身性中性粒细胞炎症和贫血有关。总之,COPD在动脉粥样硬化性动脉疾病患者中高度流行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3822/5655122/1c6f01502fd7/copd-12-3047Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3822/5655122/54cfa21e5a7f/copd-12-3047Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3822/5655122/2d03d15f198a/copd-12-3047Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3822/5655122/1c6f01502fd7/copd-12-3047Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3822/5655122/54cfa21e5a7f/copd-12-3047Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3822/5655122/2d03d15f198a/copd-12-3047Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3822/5655122/1c6f01502fd7/copd-12-3047Fig3.jpg

相似文献

1
High prevalence of COPD in atherosclerosis patients.慢性阻塞性肺疾病在动脉粥样硬化患者中的高患病率。
Int J Chron Obstruct Pulmon Dis. 2017 Oct 19;12:3047-3053. doi: 10.2147/COPD.S141988. eCollection 2017.
2
Peripheral arterial disease in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的外周动脉疾病
Int Angiol. 2012 Oct;31(5):444-53.
3
What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.不同肺量计标准对肺量计定义的慢性阻塞性肺疾病(COPD)及其合并症患病率有何影响?基于人群的德国健康访谈与检查调查(KORA)研究结果
Int J Chron Obstruct Pulmon Dis. 2016 Aug 16;11:1881-94. doi: 10.2147/COPD.S104529. eCollection 2016.
4
Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.非吸烟慢性阻塞性肺疾病患者与吸烟慢性阻塞性肺疾病患者的临床特征比较:一项回顾性观察研究。
Int J Chron Obstruct Pulmon Dis. 2014;9:57-63. doi: 10.2147/COPD.S52416. Epub 2014 Jan 8.
5
Atherosclerotic calcification in major vessel beds in chronic obstructive pulmonary disease: The Rotterdam Study.慢性阻塞性肺疾病主要血管床的动脉粥样硬化钙化:鹿特丹研究。
Atherosclerosis. 2019 Dec;291:107-113. doi: 10.1016/j.atherosclerosis.2019.10.014. Epub 2019 Oct 24.
6
Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors.当考虑到经典心血管危险因素时,缺血性心脏病与 COPD 并无关联。
Int J Chron Obstruct Pulmon Dis. 2010 Nov 8;5:387-94. doi: 10.2147/copd.s14063.
7
Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.循环中纤溶酶原激活物抑制剂-1(PAI-1)水平升高与慢性阻塞性肺疾病患者的肺功能下降、全身炎症及小气道阻塞有关。
Int J Chron Obstruct Pulmon Dis. 2016 Sep 26;11:2369-2376. doi: 10.2147/COPD.S107409. eCollection 2016.
8
Sarcopenia correlates with systemic inflammation in COPD.肌肉减少症与慢性阻塞性肺疾病中的全身炎症相关。
Int J Chron Obstruct Pulmon Dis. 2017 Feb 20;12:669-675. doi: 10.2147/COPD.S130790. eCollection 2017.
9
The effect of comorbidities on COPD assessment: a pilot study.合并症对慢性阻塞性肺疾病评估的影响:一项试点研究。
Int J Chron Obstruct Pulmon Dis. 2015 Feb 25;10:429-38. doi: 10.2147/COPD.S76124. eCollection 2015.
10
Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease.根据慢性阻塞性肺疾病的主要表型和严重程度划分的合并症患病率。
Int J Chron Obstruct Pulmon Dis. 2016 Sep 14;11:2229-2236. doi: 10.2147/COPD.S111724. eCollection 2016.

引用本文的文献

1
Analysis of the Comorbid Course of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病共病病程分析
J Pers Med. 2023 Jul 24;13(7):1179. doi: 10.3390/jpm13071179.
2
Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.动脉粥样硬化中炎症消退的分子药理学。
Int J Mol Sci. 2022 Apr 27;23(9):4808. doi: 10.3390/ijms23094808.
3
[ capsule modulates immune function by targeting multiple immune cell subsets in lung tissue of patients with COPD].[胶囊通过靶向慢性阻塞性肺疾病患者肺组织中的多个免疫细胞亚群来调节免疫功能]

本文引用的文献

1
The impact of anaemia and iron deficiency in chronic obstructive pulmonary disease: A clinical overview.慢性阻塞性肺疾病中贫血和缺铁的影响:临床概述
Rev Port Pneumol (2006). 2017 May-Jun;23(3):146-155. doi: 10.1016/j.rppnen.2016.12.005. Epub 2017 Feb 21.
2
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.慢性阻塞性肺疾病全球策略:诊断、管理与预防 2017 年报告。GOLD 执行摘要。
Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP.
3
COPD: A stepwise or a hit hard approach?
Nan Fang Yi Ke Da Xue Xue Bao. 2021 Oct 20;41(10):1492-1500. doi: 10.12122/j.issn.1673-4254.2021.10.07.
4
The Role of ABC Transporters in Lipid Metabolism and the Comorbid Course of Chronic Obstructive Pulmonary Disease and Atherosclerosis.ABC 转运蛋白在脂代谢及慢性阻塞性肺疾病和动脉粥样硬化合并症中的作用。
Int J Mol Sci. 2021 Jun 23;22(13):6711. doi: 10.3390/ijms22136711.
5
Prevalence of different comorbidities in chronic obstructive pulmonary disease among Shahrekord PERSIAN cohort study in southwest Iran.伊朗西南部沙赫雷克库尔德 PERSIAN 队列研究中慢性阻塞性肺疾病患者的不同合并症患病率。
Sci Rep. 2021 Jan 15;11(1):1548. doi: 10.1038/s41598-020-79707-y.
6
Implications of Managing Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases.慢性阻塞性肺疾病在心血管疾病中的管理意义
Tuberc Respir Dis (Seoul). 2021 Jan;84(1):35-45. doi: 10.4046/trd.2020.0088. Epub 2020 Oct 13.
7
Shared mechanisms of multimorbidity in COPD, atherosclerosis and type-2 diabetes: the neutrophil as a potential inflammatory target.COPD、动脉粥样硬化和 2 型糖尿病中多种疾病共病的共同机制:中性粒细胞作为潜在的炎症靶点。
Eur Respir Rev. 2020 Mar 20;29(155). doi: 10.1183/16000617.0102-2019. Print 2020 Mar 31.
8
Increased risk of peripheral arterial occlusive diseases in patients with chronic obstructive pulmonary disease: a nationwide study in Taiwan.慢性阻塞性肺疾病患者外周动脉闭塞性疾病风险增加:台湾一项全国性研究。
Int J Chron Obstruct Pulmon Dis. 2019 Jul 4;14:1455-1464. doi: 10.2147/COPD.S202029. eCollection 2019.
9
Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD.可溶性尿激酶型纤溶酶原激活物受体与 COPD 患者的动脉僵硬度。
Lung. 2019 Apr;197(2):189-197. doi: 10.1007/s00408-019-00211-w. Epub 2019 Feb 28.
慢性阻塞性肺疾病:逐步治疗还是重拳出击?
Rev Port Pneumol (2006). 2016 Jul-Aug;22(4):214-21. doi: 10.1016/j.rppnen.2015.12.012. Epub 2016 Feb 27.
4
Airflow Limitation and Endothelial Dysfunction. Unrelated and Independent Predictors of Atherosclerosis.气流受限与内皮功能障碍:动脉粥样硬化的无关且独立预测因素
Am J Respir Crit Care Med. 2016 Jul 1;194(1):38-47. doi: 10.1164/rccm.201510-2093OC.
5
Body Plethysmography is Helpful for COPD Diagnosis, Determination of Severity, Phenotyping, and Response to Therapy.体容积描记法有助于慢性阻塞性肺疾病的诊断、严重程度判定、表型分析及治疗反应评估。
COPD. 2015;12(6):591-4. doi: 10.3109/15412555.2015.1043524. Epub 2015 Sep 29.
6
Effects of post-sampling analysis time, type of blood samples and collection tubes on values of blood gas testing.采样后分析时间、血样类型及采血管对血气检测值的影响。
Med Glas (Zenica). 2015 Aug;12(2):108-12. doi: 10.17392/823-15.
7
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease.一项关于慢性阻塞性肺疾病患者队列中铁缺乏症患病率及相关性的横断面研究。
BMJ Open. 2015 Jul 6;5(7):e007911. doi: 10.1136/bmjopen-2015-007911.
8
High prevalence of peripheral arterial disease in patients with obstructive sleep apnoea.阻塞性睡眠呼吸暂停患者外周动脉疾病患病率高。
Clin Res Cardiol. 2015 Sep;104(9):719-26. doi: 10.1007/s00392-015-0834-3. Epub 2015 Mar 1.
9
Common genetic determinants of lung function, subclinical atherosclerosis and risk of coronary artery disease.肺功能、亚临床动脉粥样硬化和冠状动脉疾病风险的常见遗传决定因素。
PLoS One. 2014 Aug 5;9(8):e104082. doi: 10.1371/journal.pone.0104082. eCollection 2014.
10
Epidemiological studies of CHD and the evolution of preventive cardiology.冠心病的流行病学研究与预防心脏病学的发展。
Nat Rev Cardiol. 2014 May;11(5):276-89. doi: 10.1038/nrcardio.2014.26. Epub 2014 Mar 25.